VLX103
Phase 2- Indications
- Gastrointestinal disease, Alcoholic hepatitis, Non-alcoholic steatohepatitis
Company intelligence / Profile preview
Verlyx Pharma Inc.
Montreal, Quebec, Canadaodanlab.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Verlyx Pharma Inc. was a Montreal-based clinical-stage biopharmaceutical company focused on developing liver-targeting therapeutic agents, including its lead compound VLX103 and analogs for gastrointestinal diseases. The company also developed new formulations of pentamidine targeting liver cancers such as hepatocellular carcinoma. At least one Phase I clinical trial was completed with an oral pentamidine formulation. In February 2024, the company was acquired by Odan Laboratories Ltd., after which it ceased independent operations. No products had received regulatory approval at the time of acquisition.
- Therapeutic areas
- GastroenterologyOncology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Verlyx Pharma Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Verlyx Pharma Inc..